- Home
- KOSS vs ANVS Comparison
KOSS vs ANVS Comparison
Compare KOSS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- ANVS
- Stock Information
- Founded
- KOSS 1953
- ANVS 2008
- Country
- KOSS United States
- ANVS United States
- Employees
- KOSS N/A
- ANVS N/A
- Industry
- KOSS Consumer Electronics/Appliances
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- ANVS Health Care
- Exchange
- KOSS Nasdaq
- ANVS Nasdaq
- Market Cap
- KOSS 49.1M
- ANVS 46.1M
- IPO Year
- KOSS N/A
- ANVS 2020
- Fundamental
- Price
- KOSS $4.78
- ANVS $2.00
- Analyst Decision
- KOSS
- ANVS Strong Buy
- Analyst Count
- KOSS 0
- ANVS 3
- Target Price
- KOSS N/A
- ANVS $13.50
- AVG Volume (30 Days)
- KOSS 57.5K
- ANVS 1.4M
- Earning Date
- KOSS 10-30-2025
- ANVS 11-12-2025
- Dividend Yield
- KOSS N/A
- ANVS N/A
- EPS Growth
- KOSS N/A
- ANVS N/A
- EPS
- KOSS N/A
- ANVS N/A
- Revenue
- KOSS $13,493,080.00
- ANVS N/A
- Revenue This Year
- KOSS N/A
- ANVS N/A
- Revenue Next Year
- KOSS N/A
- ANVS N/A
- P/E Ratio
- KOSS N/A
- ANVS N/A
- Revenue Growth
- KOSS 11.58
- ANVS N/A
- 52 Week Low
- KOSS $4.00
- ANVS $1.11
- 52 Week High
- KOSS $8.59
- ANVS $9.23
- Technical
- Relative Strength Index (RSI)
- KOSS 40.30
- ANVS 46.35
- Support Level
- KOSS $4.75
- ANVS $1.97
- Resistance Level
- KOSS $5.19
- ANVS $2.29
- Average True Range (ATR)
- KOSS 0.31
- ANVS 0.17
- MACD
- KOSS -0.01
- ANVS 0.02
- Stochastic Oscillator
- KOSS 6.12
- ANVS 59.47
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.